BTIG Reiterates Buy Rating on Haemonetics (HAE)

June 26, 2026 5:45 AM

BTIG analyst Marie Thibault reiterated a Buy rating and $64.00 price target on Haemonetics (NYSE: HAE).The analyst commented: "Earlier this ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found